Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 2/20 | 0.35 |
| ▸ | CA2 | P00918 | 2/20 | 0.35 |
| ▸ | CA4 | P22748 | 2/20 | 0.35 |
| ▸ | CA9 | Q16790 | 2/20 | 0.35 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL657861 | 0.92 | CA1 (0.40) | CA1CA2CA4CA9TAAR1 | |
| SCHEMBL651045 | 0.92 | CA1 (0.39) | CA1CA2CA4CA9TAAR1 | |
| SCHEMBL62392 | 0.86 | CA1 (0.35) | CA1CA2CA4CA9TAAR1 | |
| SCHEMBL5032600 | 0.84 | CA1 (0.38) | CA1CA2CA4CA9TAAR1 | |
| SCHEMBL83681 | 0.84 | CA1 (0.44) | CA1CA2CA4CA9TAAR1 | |
| SCHEMBL1767625 | 0.83 | KDM4E (0.39) | CA1CA2CA4CA9 | |
| SCHEMBL182978 | 0.83 | CA1 (0.35) | CA1CA2CA4CA9 | |
| SCHEMBL308664 | 0.81 | CA1 (0.37) | CA1CA2CA4CA9 | |
| Sulfuric Acid SCHEMBL28700686 | 0.81 | CA1 (0.46) | CA1CA2CA4CA9TAAR1 | |
| SCHEMBL1007938 | 0.79 | ALDH1A1 (0.37) | CA1CA2CA9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1818334-B1 | ANTI-TRYPANOSOMIASIS AGENT | IHARA MASATAKA (JP) | 2011-11-02 | — | — | EP | disclosed |
| US-20110021450-A1 | MEDICINAL COMPOSITION CONTAINING BENZO[A]PHENOXAZINE COMPOUND AS THE ACTIVE INGREDIENT FOR PREVENTION OR TREATMENT OF PROTOZOAL DISEASE | HOSHI UNIVERSITY (JP) | 2011-01-27 | — | — | US | disclosed |
| EP-2269996-A1 | MEDICINAL COMPOSITION CONTAINING BENZO[A]PHENOXANTHIN COMPOUND AS THE ACTIVE INGREDIENT FOR PREVENTING OR TREATING PROTOZOAL DISEASE | Hoshi University (JP) | 2011-01-05 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110021450-A1 | MEDICINAL COMPOSITION CONTAINING BENZO[A]PHENOXAZINE COMPOUND AS THE ACTIVE INGREDIENT FOR PREVENTION OR TREATMENT OF PROTOZOAL DISEASE | TBCA, THPO, PAOX | CA1 2968/4885CA2 1023/4885CA4 3362/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.